STING1 and neoplasm: This disruption leads to the accumulation of cytoplasmic telomeric DNA fragments that are recognized by DCs, thereby activating the cGAS-STING pathway, promoting IFN-I production, and enhancing T cell-mediated anti-tumor immunity (Figure 5).